The Journal of Practical Medicine >
Research progress in T cell exhaustion and its relationship with respiratory diseases
Received date: 2023-12-28
Online published: 2024-07-09
T cell exhaustion occurs mostly in chronic infections， cancers and autoimmune diseases. Continuous antigenic stimulation leads to the generation of exhausted T cells， which is characterized by progressive loss of effector function， continuous high expression of inhibitory receptors， transcription and epigenetic changes， and metabolic disorders. The in-depth study of the specific mechanism of T cell exhaustion is providing new ideas for the immunotherapy of chronic infection， lung cancer and chronic airway inflammatory disease in respiratory diseases. This paper discussed the influencing factors and characteristics of T cell exhaustion and reviewed the current research status of T cell exhaustion and respiratory diseases.
Ziqi DING , Qian. ZHANG . Research progress in T cell exhaustion and its relationship with respiratory diseases[J]. The Journal of Practical Medicine, 2024 , 40(13) : 1895 -1900 . DOI: 10.3969/j.issn.1006-5725.2024.13.023
| 1 | GALLIMORE A， GLITHERO A， GODKIN A， et al. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes［J］. J Exp Med， 1998，187（9）：1383-1393. doi:10.1084/jem.187.9.1383 |
| 2 | SHIN M S， PARK H J， YOUNG J， et al. Implication of IL-7 receptor alpha chain expression by CD8+ T cells and its signature in defining biomarkers in aging［J］. Immun Ageing， 2022，19（1）：1-8. doi:10.1186/s12979-022-00324-6 |
| 3 | WHERRY E J. T cell exhaustion［J］. Nat Immunol， 2011， 12（6）：492-499. doi:10.1038/ni.2035 |
| 4 | LENG A， SHAH M， AHMAD S A， et al. Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics［J］. Cells， 2023，12（5）：816. doi:10.3390/cells12050816 |
| 5 | OSUCH S， LASKUS T， PERLEJEWSKI K， et al. CD8+ T-cell exhaustion phenotype in chronic hepatitis c virus infection is associated with epitope sequence variation［J］. Front Immunol， 2022，13：903. doi:10.3389/fimmu.2022.832206 |
| 6 | MISHRA K， SINGH M， SARASWAT D， et al. Dysfunctional state of T cells or exhaustion during chronic viral infections and COVID-19： A review［J］. Viral Immunol， 2022，35（4）：284-290. doi:10.1089/vim.2022.0002 |
| 7 | GAO Z， FENG Y， XU J， et al. T-cell exhaustion in immune-mediated inflammatory diseases： New implications for immunotherapy［J］. Front Immunol， 2022，13：977394. doi:10.3389/fimmu.2022.977394 |
| 8 | DOLINA J S， BRAECKEL-BUDIMIR N V， THOMAS G D， et al. CD8+ T cell exhaustion in cancer［J］. Front Immunol， 2021，12：715234. doi:10.3389/fimmu.2021.715234 |
| 9 | BARNOVA M， BOBCAKOVA A， URDOVA V， et al. Inhibitory immune checkpoint molecules and exhaustion of T cells in COVID-19［J］. Physiol Res， 2021，70（S2）：S227-S247. |
| 10 | QUIGLEY M， PEREYRA F， NILSSON B， et al.Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF［J］. Nat Med，2010，16（10）：1147-1151. doi:10.1038/nm.2232 |
| 11 | HAN Y， LIU D， LI L. PD-1/PD-L1 pathway： current researches in cancer［J］. Am J Cancer Res， 2020，10（3）：727-742. |
| 12 | BROOKS D G， TRIFILO M J， EDELMANN K H， et al. Interleukin-10 determines viral clearance or persistence in vivo［J］. Nat Med， 2006，12（11）：1301-1309. doi:10.1038/nm1492 |
| 13 | HASHIMOTO M， ARAKI K， CARDENAS M A， et al. PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program［J］. Nature， 2022，610（7930）：173-181. doi:10.1038/s41586-022-05257-0 |
| 14 | HU Y， HUDSON W H， KISSICK H T， et al. TGF-beta regulates the stem-like state of PD-1+ TCF-1+ virus-specific CD8 T cells during chronic infection［J］. J Exp Med， 2022，219（10） ：e20211574. doi:10.1084/jem.20211574 |
| 15 | ELSAESSER H， SAUER K， BROOKS D G. IL-21 is required to control chronic viral infection［J］. Science， 2009， 324（5934）：1569-1572. doi:10.1126/science.1174182 |
| 16 | CUI C， WANG J， FAGERBERG E， et al. Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses［J］. Cell，2021，184（25）：6101-6118. doi:10.1016/j.cell.2021.11.007 |
| 17 | REN H M， LUKACHER A E， RAHMAN Z S M， et al. New developments implicating IL-21 in autoimmune disease［J］. J Autoimmun，2021，122：102689. doi:10.1016/j.jaut.2021.102689 |
| 18 | ELAHI S， SHAHBAZ S， HOUSTON S. Selective upregulation of CTLA-4 on CD8+ T cells restricted by HLA-B* 35Px renders them to an exhausted phenotype in HIV-1 infection［J］. PLoS Pathog， 2020，16（8）：e1008696. doi:10.1371/journal.ppat.1008696 |
| 19 | OYEWOLE-SAID D， KONDURI V， VAZQUEZ-PEREZ J， et al. Beyond T-cells： functional characterization of CTLA-4 expression in immune and non-immune cell types［J］. Front Immunol， 2020，11：608024. doi:10.3389/fimmu.2020.608024 |
| 20 | CHOCARRO L， BLANCO E， ZUAZO M， et al. Understanding LAG-3 signaling［J］. Int J Mol Sci， 2021，22（10）：5282. doi:10.3390/ijms22105282 |
| 21 | HAN J， WAN M， MA Z， et al. The TOX subfamily： all-round players in the immune system［J］. Clin Exp Immunol， 2022，208（3）：268-280. doi:10.1093/cei/uxac037 |
| 22 | SEN D R， KAMINSKI J， BARNITZ R A， et al. The epigenetic landscape of T cell exhaustion［J］. Science， 2016， 354（6316）：1165-1169. doi:10.1126/science.aae0491 |
| 23 | 刘勋. 结核抗原持续刺激致T细胞耗竭实验研究及亚单位疫苗LT70-DPC的研发［D］. 兰州：兰州大学， 2016. |
| 24 | PHILLIPS B L， MEHRA S， AHSAN M H， et al. LAG3 expression in active mycobacterium tuberculosis infections［J］. Am J Pathol， 2015，185（3）：820-833. doi:10.1016/j.ajpath.2014.11.003 |
| 25 | SHEN L， GAO Y， LIU Y， et al. PD-1/PD-L pathway inhibits M.tb-specific CD4+ T-cell functions and phagocytosis of macrophages in active tuberculosis［J］. Sci Rep， 2016，6：38362. doi:10.1038/srep38362 |
| 26 | JAYARAMAN P， JACQUES M K， ZHU C， et al. TIM3 mediates T cell exhaustion during mycobacterium tuberculosis infection［J］. PLoS Pathog， 2016，12（3）：e1005490. doi:10.1371/journal.ppat.1005490 |
| 27 | LOMBARDI A， VILLA S， CASTELLI V， et al. T-Cell Exhaustion in Mycobacterium tuberculosis and Nontuberculous Mycobacteria Infection： Pathophysiology and Therapeutic Perspectives［J］. Microorganisms， 2021，9（12）：2460. doi:10.3390/microorganisms9122460 |
| 28 | LIU X， LI F， NIU H， et al. IL-2 Restores T-Cell Dysfunction Induced by Persistent Mycobacterium tuberculosis Antigen Stimulation［J］. Front Immunol， 2019， 10：2350. doi:10.3389/fimmu.2019.02350 |
| 29 | RHA M S， SHIN E C. Activation or exhaustion of CD8+ T cells in patients with COVID-19［J］. Cell Mol Immunol， 2021，18（10）：2325-2333. doi:10.1038/s41423-021-00750-4 |
| 30 | LIU L， WANG A， LIU X， et al. Blocking TIGIT/CD155 signalling reverses CD8+ T cell exhaustion and enhances the antitumor activity in cervical cancer［J］. J Transl Med， 2022，20（1）：1-13. doi:10.1186/s12967-022-03480-x |
| 31 | SIEGEL R L， MILLER K D， WAGLE N S， et al. Cancer statistics， 2023［J］. CA Cancer J Clin， 2023，73（1）：17-48. doi:10.3322/caac.21763 |
| 32 | DUTTA S， GANGULY A， CHATTERJEE K， et al. Targets of immune escape mechanisms in cancer： basis for development and evolution of cancer immune checkpoint inhibitors［J］. Biology （Basel）， 2023，12（2）：218. doi:10.3390/biology12020218 |
| 33 | CHI X， LUO S， YE P， et al. T-cell exhaustion and stemness in antitumor immunity： characteristics， mechanisms， and implications［J］. Front Immunol， 2023，14：1104771. doi:10.3389/fimmu.2023.1104771 |
| 34 | CHU X， TIAN W， WANG Z， et al. Co-inhibition of TIGIT and PD-1/PD-L1 in cancer immunotherapy： mechanisms and clinical trials［J］. Mol Cancer， 2023，22（1）：1-31. doi:10.1186/s12943-023-01800-3 |
| 35 | SU Y， YAMAZAKI S， MORISUE R， et al. Tumor-infiltrating T cells concurrently overexpress CD200R with immune checkpoints PD-1， CTLA-4， and TIM-3 in non-small-cell lung cancer［J］. Pathobiology， 2021，88（3）：218-227. doi:10.1159/000511557 |
| 36 | 武阳，陆翰杰，水会锋. 既往免疫经治的晚期非小细胞肺癌患者接受安罗替尼联合PD?1单抗的疗效及安全性［J］. 实用医学杂志， 2023，39（5）：572-578. |
| 37 | ITAHASHI K， IRIE T， YUDA J， et al. BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors［J］. Sci Immunol， 2022，7（76）：eabk0957. doi:10.1126/sciimmunol.abk0957 |
| 38 | ZHANG Z， LIN M， WANG J， et al. Calycosin inhibits breast cancer cell migration and invasion by suppressing EMT via BATF/TGF-β1［J］. Aging （Albany NY）， 2021，13（12）：16009-16023. doi:10.18632/aging.203093 |
| 39 | ZHANG X， ZHANG C， QIAO M， et al. Depletion of BATF in CAR-T cells enhances antitumor activity by inducing resistance against exhaustion and formation of central memory cells［J］. Cancer Cell， 2022，40（11）：1407-1422. doi:10.1016/j.ccell.2022.09.013 |
| 40 | TREFNY M P， KIRCHHAMMER N， DER MAUR P AUF， et al. Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy［J］. Nat Commun， 2023，14（1）：86. doi:10.1038/s41467-022-35583-w |
| 41 | ZHANG H， LIU S， LI Y， et al. Dysfunction of S100A4+ effector memory CD8+ T cells aggravates asthma［J］. Eur J Immunol，2022，52（6）：978-993. doi:10.1002/eji.202149572 |
| 42 | DIEHL S， KRAHL T， RINALDI L， et al. Inhibition of NFAT specifically in T cells prevents allergic pulmonary inflammation［J］. J Immunol， 2004，172（6）：3597-3603. doi:10.4049/jimmunol.172.6.3597 |
| 43 | LIN M， HUANG Z， CHEN Y， et al. Lung cancer patients with chronic obstructive pulmonary disease benefit from anti-PD-1/PD-L1 therapy［J］. Front Immunol， 2022，13：1038715. doi:10.3389/fimmu.2022.1038715 |
/
| 〈 |
|
〉 |